PEDIATRIX MEDICAL GROUP INC (MD) Stock Analyst Earnings Estimates
NYSE:MD - New York Stock Exchange, Inc. - US58502B1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.972B 3.18% | 1.995B 1.15% | 2.013B 0.92% | 1.93B -4.12% | 1.993B 3.26% | 2.09B 4.87% | 2.194B 4.98% | 2.298B 4.74% | |
| EBITDA YoY % growth | 235.636M -5.70% | 194.023M -17.66% | 215.907M 11.28% | 239.54M 10.95% | 248.83M 3.88% | 258.57M 3.91% | N/A | N/A | |
| EBIT YoY % growth | 200M -8.15% | 157.852M -21.07% | 183.681M 16.36% | 209.5M 14.06% | 218.84M 4.46% | 227.15M 3.80% | N/A | N/A | |
| Operating Margin | 10.14% | 7.91% | 9.13% | 10.85% | 10.98% | 10.87% | N/A | N/A | |
| EPS YoY % growth | 1.67 2.45% | 1.26 -24.55% | 1.49 18.25% | 1.71 15.09% | 1.77 3.17% | 1.81 2.57% | 1.64 -9.75% | 1.60 -2.52% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.45 2.53% | 0.49 -4.80% | 0.33 -0.67% | 0.42 -19.88% | 0.44 -2.91% | 0.50 3.42% | 0.28 -14.53% | 0.47 10.78% | 0.48 10.37% | 0.55 8.86% |
| Revenue Q2Q % growth | 487.08M -4.71% | 492.67M -1.93% | 487.88M 6.44% | 488.35M 4.16% | 502.05M 3.07% | 510.93M 3.71% | 502.34M 2.96% | 513.73M 5.20% | 524.98M 4.57% | 533.85M 4.49% |
| EBITDA Q2Q % growth | 62.766M -19.32% | 67.837M -24.90% | 48.635M 10.44% | 64.869M -12.75% | 66.932M 6.64% | 69.299M 2.16% | 45.542M -6.36% | 69.015M 6.39% | 71.35M 6.60% | 78.663M 13.51% |
| EBIT Q2Q % growth | 55.415M 5.66% | 59.677M 2.71% | 40.645M 5.01% | 58.117M -8.77% | 59.93M 8.15% | 66.545M 11.51% | 38.142M -6.16% | 61.429M 5.70% | 63.614M 6.15% | 70.588M 6.08% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.53 55.88% | 0.44 | 0.09 | 21.14% |
| Q1 2025 Q2Q % growth | 0.33 65.00% | 0.25 | 0.08 | 32.73% |
| Q4 2024 Q2Q % growth | 0.51 59.38% | 0.38 | 0.13 | 34.96% |
| Q3 2024 Q2Q % growth | 0.44 37.50% | 0.38 | 0.06 | 15.90% |
| Q2 2024 Q2Q % growth | 0.34 -12.82% | 0.32 | 0.02 | 5.21% |
| Q1 2024 Q2Q % growth | 0.20 -13.04% | 0.19 | 0.01 | 4.25% |
| Q4 2023 Q2Q % growth | 0.32 -31.91% | 0.33 | -0.01 | -4.41% |
| Q3 2023 Q2Q % growth | 0.32 -20.00% | 0.45 | -0.13 | -28.23% |
| Q2 2023 Q2Q % growth | 0.39 -17.02% | 0.41 | -0.02 | -5.81% |
| Q1 2023 Q2Q % growth | 0.23 -30.30% | 0.24 | -0.01 | -2.38% |
| Q4 2022 Q2Q % growth | 0.47 -9.62% | 0.50 | -0.03 | -5.68% |
| Q3 2022 Q2Q % growth | 0.40 -13.04% | 0.56 | -0.16 | -29.04% |
| Q2 2022 Q2Q % growth | 0.47 14.63% | 0.49 | -0.02 | -4.02% |
| Q1 2022 Q2Q % growth | 0.33 37.50% | 0.28 | 0.05 | 17.55% |
| Q4 2021 Q2Q % growth | 0.52 108.00% | 0.45 | 0.07 | 15.71% |
| Q3 2021 Q2Q % growth | 0.46 24.32% | 0.43 | 0.03 | 7.43% |
| Q2 2021 Q2Q % growth | 0.41 28.12% | 0.33 | 0.08 | 22.72% |
| Q1 2021 Q2Q % growth | 0.24 -25.00% | 0.14 | 0.10 | 75.63% |
| Q4 2020 Q2Q % growth | 0.25 -72.53% | 0.37 | -0.12 | -31.88% |
| Q3 2020 Q2Q % growth | 0.37 -59.34% | 0.42 | -0.05 | -10.88% |
| Q2 2020 Q2Q % growth | 0.32 -64.04% | 0.09 | 0.23 | 248.30% |
| Q1 2020 Q2Q % growth | 0.32 -50.77% | 0.56 | -0.24 | -42.56% |
| Q4 2019 Q2Q % growth | 0.91 | 0.93 | -0.02 | -1.99% |
| Q3 2019 Q2Q % growth | 0.91 | 0.93 | -0.02 | -2.38% |
| Q2 2019 Q2Q % growth | 0.89 | 0.88 | 0.01 | 0.74% |
| Q1 2019 Q2Q % growth | 0.65 | 0.72 | -0.07 | -9.62% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 468.84M -7.03% | 478.25M | -9.41M | -1.97% |
| Q1 2025 Q2Q % growth | 458.359M -7.42% | 465.04M | -6.681M | -1.44% |
| Q4 2024 Q2Q % growth | 502.364M 1.19% | 500.79M | 1.574M | 0.31% |
| Q3 2024 Q2Q % growth | 511.158M 0.90% | 513.83M | -2.672M | -0.52% |
| Q2 2024 Q2Q % growth | 504.296M 0.74% | 520.66M | -16.364M | -3.14% |
| Q1 2024 Q2Q % growth | 495.101M 0.83% | 514.05M | -18.949M | -3.69% |
| Q4 2023 Q2Q % growth | 496.443M -3.39% | 539.04M | -42.597M | -7.90% |
| Q3 2023 Q2Q % growth | 506.612M 3.41% | 523.5M | -16.888M | -3.23% |
| Q2 2023 Q2Q % growth | 500.577M 2.99% | 510.73M | -10.153M | -1.99% |
| Q1 2023 Q2Q % growth | 491.008M 1.82% | 505.5M | -14.492M | -2.87% |
| Q4 2022 Q2Q % growth | 513.844M 3.07% | 517.05M | -3.206M | -0.62% |
| Q3 2022 Q2Q % growth | 489.915M -0.62% | 527.11M | -37.195M | -7.06% |
| Q2 2022 Q2Q % growth | 486.033M 2.76% | 506.28M | -20.247M | -4.00% |
| Q1 2022 Q2Q % growth | 482.229M 7.93% | 488.42M | -6.191M | -1.27% |
| Q4 2021 Q2Q % growth | 498.53M 19.67% | 498.34M | 190K | 0.04% |
| Q3 2021 Q2Q % growth | 492.949M 7.02% | 494.45M | -1.501M | -0.30% |
| Q2 2021 Q2Q % growth | 472.959M 13.86% | 462.41M | 10.549M | 2.28% |
| Q1 2021 Q2Q % growth | 446.8M 1.27% | 436.85M | 9.95M | 2.28% |
| Q4 2020 Q2Q % growth | 416.6M -9.16% | 473.33M | -56.73M | -11.99% |
| Q3 2020 Q2Q % growth | 460.6M 112.36% | 551.45M | -90.85M | -16.47% |
| Q2 2020 Q2Q % growth | 415.4M -25.98% | 572.6M | -157.2M | -27.45% |
| Q1 2020 Q2Q % growth | 441.2M -18.75% | 878.02M | -436.82M | -49.75% |
| Q4 2019 Q2Q % growth | 458.6M | 928.24M | -469.64M | -50.59% |
| Q3 2019 Q2Q % growth | 216.9M | 902.53M | -685.63M | -75.97% |
| Q2 2019 Q2Q % growth | 561.2M | 894.76M | -333.56M | -37.28% |
| Q1 2019 Q2Q % growth | 543M | 933.6M | -390.6M | -41.84% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 3.67% | 0% | 7.97% |
| Revenue | 0% | -0.19% | 0% | 0.52% |